What is being built?

Egis Pharmaceuticals inaugurates new active ingredient manufacturing plant in the capital city

Published

A bird's-eye view of the new Budapest plant. Photo: Egis
The brownfield investment in Kőbánya was financed by the company from its own resources.

Egis Gyógyszergyár Zrt. has unveiled one of the most significant developments in its 112-year history in Budapest. The company will manufacture the active ingredient for a globally leading product at its new HUF 30 billion plant, financed from its own resources, the company announced on Thursday.

According to the announcement, the unique feature of the brownfield investment project implemented in Kőbánya is that

The technology is almost identical to that used at the French parent company's plant in Normandy, and once operational, it will double the production of the active ingredient needed for the Servier Group's drug for treating venous disorders.

They wrote: In recent decades, the general trend in Europe has been a decline and outsourcing of active ingredient production. In contrast, Egis has rebuilt and renewed its active ingredient production over the past 12 years.

A modern, multi-level manufacturing plant was built.

As a vertically integrated European company, Egis researches, develops and manufactures active pharmaceutical ingredients and preparations in Europe, which it sells worldwide, according to Csaba Poroszlai, CEO of Egis Gyógyszergyár Zrt., who added that

The new plant provides capacities that will secure the foundations for long-term development and competitiveness, and contribute to security of supply.

During the four-year project, a modern, multi-level manufacturing plant was built, which uses state-of-the-art technical and quality assurance solutions – this can be read on the pharmaceutical company's website.

In addition to the recently completed investment in Budapest, Egis is continuously strengthening its production capacities and market presence. This summer, the company announced that it would be further modernising its Körmend site with developments worth more than HUF 14 billion. Since 2018, investments worth almost HUF 29 billion have been made at this site with state support, creating new jobs.

Source: Link

Popular